Ardelyx (ARDX) Change in Accured Expenses (2013 - 2026)
Ardelyx (ARDX) posted Change in Accured Expenses of $19.0 million for Q1 2026, up 369.45% on a QoQ basis from $4.1 million in Q4 2025, and up 136.5% year-over-year from $8.0 million in Q1 2025.
Ardelyx (ARDX) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Ardelyx's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $19.0 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 136.5% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (down 31.58% YoY) and the FY2025 annual result came in at $4.2 million, down 80.39% from the prior year.
- Change in Accured Expenses was $19.0 million for Q1 2026 at Ardelyx, up from $4.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $22.3 million in Q4 2024 and bottomed at -$13.0 million in Q3 2024.
- A 5-year average of $3.1 million and a median of $1.8 million in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 903.96% in 2024, while the deepest fall reached 282.27% in 2024.
- Ardelyx's Change in Accured Expenses stood at $2.4 million in 2022, then slumped by 215.87% to -$2.8 million in 2023, then surged by 903.96% to $22.3 million in 2024, then slumped by 81.84% to $4.1 million in 2025, then soared by 369.45% to $19.0 million in 2026.
- Business Quant data shows ARDX's Change in Accured Expenses at $19.0 million in Q1 2026, $4.1 million in Q4 2025, and -$7.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 19.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.02 Mn |
| Mar 31, 2026 | 19.02 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Sep 30, 2025 | -7.36 Mn |
| Sep 30, 2025 | -7.36 Mn |
| Jun 30, 2025 | -563,000.00 |
| Jun 30, 2025 | -563,000.00 |
| Mar 31, 2025 | 8.04 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Dec 31, 2024 | 22.31 Mn |
| Dec 31, 2024 | 22.31 Mn |
| Sep 30, 2024 | -13.00 Mn |
| Sep 30, 2024 | -13.00 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Mar 31, 2024 | 7.16 Mn |
| Mar 31, 2024 | 7.16 Mn |
| Dec 31, 2023 | -2.78 Mn |
| Dec 31, 2023 | -2.78 Mn |